Literature DB >> 10508495

ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells.

A Fernandes1, A W Hamburger, B I Gerwin.   

Abstract

Overexpression of the growth factor receptor ErbB-2/Her2/Neu has been implicated in the development of non-small-cell lung cancer. We have reported that the transformation of human lung epithelial cells by c-erbB-2 also requires an active ErbB-1 (EGF receptor) and the autocrine production of its ligand, TGF-alpha. In this report, we demonstrate that STAT 3 is constitutively activated in these cells by the TGF-alpha-stimulated ErbB-1/-2 heterodimer complex. STAT 3 activation was confirmed by mobility shift assays and nuclear localization. ErbB-1 was required, but not sufficient for the TGF-alpha-induced activation of STATs. Inhibition of ErbB-2 kinase activity by tyrphostin AG825 prevented the constitutive activation of STAT 3 in the TGF-alpha-producing, ErbB-1 expressing cell line. Our results demonstrate a requirement for ErbB-2 kinase activity to establish constitutive STAT 3 activation resulting from an autocrine ErbB-1/ TGF-alpha loop. Int. J. Cancer 83:564-570, 1999. Published 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508495     DOI: 10.1002/(sici)1097-0215(19991112)83:4<564::aid-ijc20>3.0.co;2-q

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

Review 1.  Stat transcription factors in mammary gland development and tumorigenesis.

Authors:  C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

2.  ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.

Authors:  Valerie S Hawthorne; Wen-Chien Huang; Christopher L Neal; Ling-Min Tseng; Mien-Chie Hung; Dihua Yu
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

3.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

4.  PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells.

Authors:  Emma Villa-Moruzzi
Journal:  Mol Cell Biochem       Date:  2012-12-02       Impact factor: 3.396

Review 5.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

6.  The role of STAT3 activation in modulating the immune microenvironment of GBM.

Authors:  Alfred P See; James E Han; Jillian Phallen; Zev Binder; Gary Gallia; Fan Pan; Dilini Jinasena; Christopher Jackson; Zineb Belcaid; Sung Jin Jeong; Chelsea Gottschalk; Jing Zeng; Jacob Ruzevick; Sarah Nicholas; Young Kim; Emilia Albesiano; Drew M Pardoll; Michael Lim
Journal:  J Neurooncol       Date:  2012-10-25       Impact factor: 4.130

7.  Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling.

Authors:  T Nakanishi; S Chumsri; N Khakpour; A H Brodie; B Leyland-Jones; A W Hamburger; D D Ross; A M Burger
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

8.  Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.

Authors:  George Z Cheng; Wei Zhou Zhang; Mei Sun; Qi Wang; Domenico Coppola; Mena Mansour; Li Mei Xu; Carliann Costanzo; Jin Q Cheng; Lu-Hai Wang
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

9.  Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.

Authors:  Mikio Tomida; Hideki Ohtake; Takashi Yokota; Yasuhito Kobayashi; Masafumi Kurosumi
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-06       Impact factor: 4.553

10.  Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner.

Authors:  Lawrence A Scheving; Mary C Stevenson; Xiuqi Zhang; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-06-05       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.